NEOG Neogen Corporation
USHealthcareAs of 2026-07-09 16:00
Why NEOG matters now
Neogen Corporation (NEOG) is a US stock in Healthcare. The latest InvestLog snapshot shows $9.75 with +5.29% on the session and $2.12B in market capitalization; recent performance reads 1-month +11.50% and YTD +33.19%.
The latest financial table shown here is Q3 2026, with revenue of $211.2M, net income of $-17.0M, and EPS of $-0.08. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.1%.
The latest indexable market news headline is "Neogen Gains 101.1% in a Year: What's Driving the Rally?" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Hold with a median target of $11.00; recent insider activity includes Moylan John Patrick filing F-InKind. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.96
P/S
2.33
EV/EBITDA
-5.93
DCF Value
$-20.75
FCF Yield
2.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
42.6%
Operating Margin
-4.4%
Net Margin
-69.9%
ROE
-29.0%
ROA
-18.1%
ROIC
-1.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $211.2M | $-17.0M | $-0.08 |
| Q2 2026 | $224.7M | $-15.9M | $-0.07 |
| Q1 2026 | $209.2M | $36.3M | $0.17 |
| Q4 2025 | $225.5M | $-612.2M | $-2.82 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$11.00
Target (Median)
$11.00
Target Range
$10.00 - $12.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
1.80
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.